Yıl: 2010 Cilt: 27 Sayı: 3 Sayfa Aralığı: 292 - 301 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment

Öz:
Amaç: Son zamanlarda Parkinson Hastalığında spinal kord patolojisi ile ilgili çalışmalara daha fazla rastlanmaktadır. H refleks incelemesi spinal kordaki nörofizyolojik ve internörinal değişiklikleri inceleyen çalışmalarda önemli bir seçenektir. Dopaminerjik tedavinin spinal internöronal refleks yollarındaki etkisi daha az araştırılmış bir konudur. Bu çalışma Parkinson Hastalığında presinaptik ve disinaptik inhibisyon düzeylerini, dopaminerjik tedavinin etkisini incelemek üzere planlanmıştır.Metod: Presinaptik inhibisyon ve disinaptik resiprokal 1a inhibisyonu Parkinson hastalarında ve normal kontrollerde 1-100 ms intervallerle peroneal sinirin ve tibial sinirin ikili uyarımı ile araştırıldı. Test ve şartlanmış H refleks yanıt amplitüd değişiklikleri hesaplandı. Dopaminerjik tedavi öncesi ve sonrası etkilenen ve daha az etkilenen taraflarda karşılaştırıldı.Bulgular: Disinaptik ve presinaptik inhibisyon tüm deneklerde mevcuttu. Disinaptik resiprokal 1 a inhibisyonu etkilenen tarafta daha kısa süreliydi ve sadece 2 ms'lik intervalde vardı. 20 ms'lik interval için şartlanmış ve test H refleks oranı (presinaptik inhibisyon) etkilenen tarafta kontrollere göre anlamlı düşük bulundu (p: 0.046). 20-10-5-3-2 ms'lik intervallerdeki inhibisyon oranları tedavi sonrası etkilenen tarafta tedavi öncesine göre anlamlı artmıştı (p: 0.031, 0.027,0.014, 0.026, 0.037).Sonuç: Parkinson hastalığında tutulan tarafta presinaptik inhibisyon azalmış, disinaptik inhibisyon süresi kısalmış bulunmuştur. Dopaminerjik tedavi, her iki inhibisyon periyodunda anlamlı artışa neden olmuştur. Bu bulgular Parkinson hastalığında supraspinal etkilerde anormallik varlığını ve ayrıca bazı dopaya cevaplı nöral mekanizmaların rolünü düşündürmüştür.
Anahtar Kelime:

Konular: Nörolojik Bilimler

Parkinson Hastalığı'nda presinaptik inhibisyon ve disinaptik resiprokal 1a inhibisyonu, dopaminerjik tedavinin etkisi

Öz:
Objective: In recent years, increasing number of studies about the spinal cord pathology in Parkinson's disease had been conducted. H reflex investigation is an important choice in the studies dealing with neurophysiological and interneuronal alterations of the spinal cord. The effect of the dopaminergic treatment on the spinal interneuronal reflex pathways is a relatively less investigated issue. This study has been adressed to assess the presynaptic and disynaptic inhibition levels in Parkinson's disease, and the effect of dopaminergic treatment.Methods: Presynaptic inhibition and dysynaptic reciprocal 1a inhibition is investigated by double stimulation of the tibial nerve at the popliteal fossa and peroneal nerve at the fibular head in patients with Parkinson's disease and also in control subjects for the 1-100 ms conditioning test intervals. The amplitude changes of the test and the conditioned H reflex responses were calculated and compared in the affected and less affected sides in both before and under dopaminergic treatment.Results: Disynaptic and presynaptic inhibitions existed in all subjects. Disynaptic reciprocal 1a inhibition was shortened only at 2 ms conditioning interval. The conditioned and test H reflex ratio (Hc/Ht) for the 20 ms conditioning test interval (presynaptic inhibition) was significantly smaller in the affected side than the controls (p: 0.046). The percentages of the inhibitions for the 20-10-5-3-2 ms conditioning intervals significantly increased in the affected side under treatment when compared with the ones obtained in the pretreatment period (p: 0.031, 0.027, 0.014, 0.026, 0.037).Conclusion: Presynaptic inhibition was decreased and disynaptic inhibition duration was shortened in the affected side of the patients with Parkinson's disease, dopaminergic treatment caused significant increases in both periods of inhibition. These findings indicate an abnormal supraspinal influence on the spinal cord in Parkinson's disease, and also the role of some dopa responsive neural mechanisms.
Anahtar Kelime:

Konular: Nörolojik Bilimler
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1) Bathien N, Rondot P. Reciprocal continuous inhibition in rigidity of Parkinsonism. J Neurol Neurosurg Psychiatry 1977;40:20-4.
  • 2) Bergui M, Lopiano L, Paglia G, Quattrocolo G, Scarzella L, Bergamasco B. Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. Acta Neurol Scand 1992;86:226-9.
  • 3) Bertolasi L, Priori A, Tinazzi M, Bertasi V, Rothwell JC Inhibitory action of forearm flexor muscle afferents on corticospinal outputs to antagonist muscles in humans. J Physiol 1998 Sep 15;511 ( Pt 3):947-56.
  • 4) Bloch A, Probst a, Bissig H, Adams H, Tolnay M. Alpha-synuclein pathology and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006; 32(3): 284-95.
  • 5) Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003 Mar-Apr;24(2):197-211.
  • 6) Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K.Stages in the development of Parkinson's disease related pathology. Cell Tissue Res 2004 Oct; 318(1):121-34.
  • 7) Butchart P, Farquhar R, Part NJ, Roberts RC. The effect of age and voluntary contraction on presynaptic inhibition of soleus muscle Ia afferent terminals in man. Exp Physiol 1993 Mar; 78(2):235-42.
  • 8) Crone C, Hultborn H, Jespersen B, Nielsen J. Reciprocal Ia inhibition between ankle flexors and extensors in man. J Physiol 1987 Aug;389:163-85.
  • 9) Crone C, Nielsen J. Central control of disynaptic reciprocal inhibition in humans. Acta Physiol Scand 1994 Dec;152(4):351-63
  • 10) Day BL, Rothwell JC, Marsden CD. Transmission in the spinal reciprocal Ia inhibitory pathway preceding willed movements of the human wrist. Neurosci Lett 1983 Jun 30;37(3):245-50.
  • 11) Day BL, Marsden CD, Obeso JA, Rothwell JC. Reciprocal inhibition between the muscles of the human forearm. J Physiol 1984 Apr;349:519-34.
  • 12) Delwaide PJ, Pepin JL, de Noordhout MA. Short-latency autogenic inhibition in patients with parkinsonian rigidity. Ann Neurol 1991;30:83–89.
  • 13) Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008 Apr;115(4):437-44.
  • 14) Fahn S, Elton RL, UPDRS program members. Unified Parkinson's disease rating scale. In Recent developments in Parkinson’s disease, Vol 2. Ed’s, Fahn S, Marsden CD, Goldstein M, Calne DB, Florham Park, NJ: Macmillan Healthcare Information, 1987, pp 153–163.
  • 15) Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991 Oct; 114:( Pt 5):2283-301.
  • 16) Fuentes R, Petersson P, Siesser WB, Caron MG, Nicolelis MA. Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science 2009 Mar 20; 323(5921):1578-82.
  • 17) Fuhr P, Zeffiro T, Hallett M. Cutaneous reflexes in Parkinson's disease. Muscle Nerve 1992;15:733-9.
  • 18) Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999 Jan;56(1):33-9.
  • 19) Hayashi A, Kagamihara Y, Nakajima Y, Narabayashi H, Okuma Y, Tanaka R. Disorder in reciprocal innervation upon initiation of voluntary movement in patients with Parkinson's disease. Exp Brain Res 1988; 70(2):437-40.
  • 20) Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42.
  • 21) Hultborn H, Meunier S, Pierrot-Deseilligny E, Shindo M.Changes in presynaptic inhibition of Ia fibres at the onset of voluntary contraction in man. J Physiol 1987 Aug; 389:757-72.
  • 22) Iacono RP, Lonser RR, Oh A, Yamada S. New pathophysiology of Parkinson's disease revealed by posteroventral pallidotomy. Neurol Res 1995 Jun;17(3):178-80.
  • 23) Iles JF, Pisini JV. Cortical modulation of transmission in spinal reflex pathways of man.J Physiol 1992 Sep; 455:425-46.
  • 24) Jackson A, Crossman AR. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience 1983 Nov;10(3):725-65.
  • 25) Jankovic J., Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008; 79;368-376
  • 26) Katz R, Meunier S, Pierrot-Deseilligny E. Changes in presynaptic inhibition in Ia fibres in man while standing. Brain 1988; 111:417–37.
  • 27) Lelli S, Panizza M, Hallett M. Spinal cord inhibitory mechanisms in Parkinson's disease. Neurology 1991;41:553-6.
  • 28) Marsden CD. Parkinson's disease.Lancet 1990 Apr 21;335(8695):948-52.
  • 29) Martinelli P, Montagna P. Conditioning of the H reflex by stimulation of the posterior tibial nerve in Parkinson's disease. J Neurol Neurosurg Psychiatry 1979 Aug;42(8):701-4.
  • 30) McLeod JG, Walsh JC. H reflex studies in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1972 Feb;35(1):77-80.
  • 31) Mercuri B, Wassermann EM, Ikoma K, Samii A, Hallett M. Effects of transcranial electrical and magnetic stimulation on reciprocal inhibition in the human arm. Electroencephalogr Clin Neurophysiol 1997 Apr; 105(2):87-93.
  • 32) Meunier S, Pol S, Houeto JL, Vidailhet M. Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease. Brain 2000 May; 123( Pt 5):1017-26.
  • 33) Mink JW.The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996 Nov; 50(4):381-425.
  • 34) Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR.Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989;32(1):213-26.
  • 35) Mizuno Y, Tanaka R, Yanagisawa N. Reciprocal group I inhibition on triceps surae motoneurons in man. J Neurophysiol 1971 Nov;34(6):1010-7.
  • 36) Movement Disorder Society Task Force on Rating Scales for PD. Unified Parkinson's disease rating scale: status and recommendations. Mov Disord 2003:18:738 –750.
  • 37) Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L; Mov Disord 2004:19(9) :1020–1028.
  • 38) Morita H, Shindo M, Yanagawa S, Yoshida T, Momoi H, Yanagisawa N. Progressive decrease in heteronymous monosynaptic Ia facilitation with human ageing. Exp Brain Res 1995; 104 :167–170.
  • 39) Morita H, Shindo M, Ikeda S, Yanagisawa N. Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease. Mov Disord 2000 Sep;15(5):830-4.
  • 40) Morita H, Crone C, Christenhuis D, Petersen NT, Nielsen JB. Modulation of presynaptic inhibition and disynaptic reciprocal Ia inhibition during voluntary movement in spasticity. Brain 2001 Apr; 124(Pt 4):826-37.
  • 41) Nakashima K, Shimoyama R, Yokoyama Y, Takahashi K. Reciprocal inhibition between the forearm muscles in patients with Parkinson's disease. Electromyogr Clin Neurophysiol 1994 Mar; 34(2):67-72.
  • 42) Nielsen J, Petersen N, Crone C. Changes in transmission across synapses of Ia afferents in spastic patients. Brain 1995 Aug; 118( Pt 4):995-1004.
  • 43) Nielsen J, Kagamihara Y.The regulation of disynaptic reciprocal Ia inhibition during co-contraction of antagonistic muscles in man. J Physiol 1992 Oct;456:373-91.
  • 44) Olsen PZ, Diamantopoulos E. Excitability of spinal motor neurones in normal subjects and patients with spasticity, Parkinsonian rigidity, and cerebellar hypotonia. J Neurol Neurosurg Psychiatry 1967 Aug;30(4):325-31.
  • 45) Öztürk A, Uysal H, Parkinson Hastalarında alfa motor nöron uyarılabilirliğinin H refleksi düzelme eğrisi ile değerlendirilmesi.Türk Nörol Derg 1998;3-4: 127-128.
  • 46) Perciavalle V. Substantia nigra influences on the reticulospinal neurons: an electrophysiological and ionophoretic study in cats and rats. Neuroscience 1987 Oct; 23(1):243-51.
  • 47) Roberts RC, Part NJ, Farquhar R, Butchart P. Presynaptic inhibition of soleous afferent terminals in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57:1488-1491.
  • 48) Rothwell JC, Obeso JA, Traub MM, Marsden CD. The behaviour of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1983; 46:35-44.
  • 49) Rothwell JC, Day BL, Berardelli A, Marsden CD. Effects of motor cortex stimulation on spinal interneurones in intact man. Exp Brain Res 1984; 54(2):382-4
  • 50) Sabbahi M, Etnyre B, Al-Jawayed IA, Hasson S, Jankovic J. Methods of H-reflex evaluation in the early stages of Parkinson's disease. J Clin Neurophysiol 2002 Jan;19(1):67-72.
  • 51) Samantaray S, Butler JT, Ray SK, Banik NL. Extranigral neurodegeneration in Parkinson's disease. Ann N Y Acad Sci 2008 Oct;1139:331-6.
  • 52) Samantaray S, Knaryan VH, Butler JT, Ray SK, Banik NL. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP. J Neurochem 2008 Mar;104(5):1309-20.
  • 53) Tsai CH, Chen RS, Lu CS. Reciprocal inhibition in Parkinson's disease. Acta Neurol Scand 1997 Jan;95(1):13-8.
  • 54) Vidailhet M, Rothwell JC, Thompson PD, Lees AJ, Marsden CD. The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease. Brain 1992 Aug; 115 ( Pt 4):1181-92.
APA Yıldız N, Aydin Turkoglu S, YILDIZ S, ALTUNRENDE B (2010). Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. , 292 - 301.
Chicago Yıldız Nebil,Aydin Turkoglu Sule,YILDIZ Serpil Kuyucu,ALTUNRENDE Burcu Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. (2010): 292 - 301.
MLA Yıldız Nebil,Aydin Turkoglu Sule,YILDIZ Serpil Kuyucu,ALTUNRENDE Burcu Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. , 2010, ss.292 - 301.
AMA Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. . 2010; 292 - 301.
Vancouver Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. . 2010; 292 - 301.
IEEE Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B "Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment." , ss.292 - 301, 2010.
ISNAD Yıldız, Nebil vd. "Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment". (2010), 292-301.
APA Yıldız N, Aydin Turkoglu S, YILDIZ S, ALTUNRENDE B (2010). Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. Journal of Neurological Sciences (Turkish), 27(3), 292 - 301.
Chicago Yıldız Nebil,Aydin Turkoglu Sule,YILDIZ Serpil Kuyucu,ALTUNRENDE Burcu Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. Journal of Neurological Sciences (Turkish) 27, no.3 (2010): 292 - 301.
MLA Yıldız Nebil,Aydin Turkoglu Sule,YILDIZ Serpil Kuyucu,ALTUNRENDE Burcu Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. Journal of Neurological Sciences (Turkish), vol.27, no.3, 2010, ss.292 - 301.
AMA Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. Journal of Neurological Sciences (Turkish). 2010; 27(3): 292 - 301.
Vancouver Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment. Journal of Neurological Sciences (Turkish). 2010; 27(3): 292 - 301.
IEEE Yıldız N,Aydin Turkoglu S,YILDIZ S,ALTUNRENDE B "Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment." Journal of Neurological Sciences (Turkish), 27, ss.292 - 301, 2010.
ISNAD Yıldız, Nebil vd. "Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment". Journal of Neurological Sciences (Turkish) 27/3 (2010), 292-301.